[Federal Register Volume 66, Number 122 (Monday, June 25, 2001)]
[Notices]
[Page 33714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-15835]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated January 25, 2001, and published in the Federal 
Register on February 14, 2001, (66 FR 10320), Cerilliant Corporation, 
14050 Summit Drive #121, P.O. Box 201088, Austin, Texas 78708-0189, 
made application to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
N-Ethylamphetamine (1475)..................  I
N, N-Dimethylamphetamine (1480)............  I
Aminorex (1585)............................  I
4-Methylaminorex (cis isomer) (1590).......  I
Gamma hydroxybutyric acid (2010)...........  I
Methaqualone (2565)........................  I
Alpha-Ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
3,4,5-Trimethoxyamphetamine................  I
4-Bromo-2, 5-dimethoxyamphetamine (7390)...  I
4-Bromo-2, 5-dimethoxyphenethylamine (7392)  I
4-Methyl-2, 5-dimethoxyamphetamine (7395)..  I
2, 5-Dimethoxyamphetamine (7396)...........  I
2, 5-Dimethoxy-4-ethylamphetamine (7399)...  I
3, 4-Methylenedioxyamphetamine (7400)......  I
5-Methoxy-3, 4-methylenedioxyamphetamine     I
 (7401).
N-Hydroxy-3, 4-methylenedioxyamphetamine     I
 (7402).
3, 4-Methylenedioxy-N-ethylamphetamine       I
 (7404).
3, 4-Methylenedioxymethamphetamine (7405)..  I
4-Methoxyamphetamine (7411)................  I
Bufotenine (7433)..........................  I
Diethyltryptamine (7434)...................  I
Dimethyltryptamine (7435)..................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
Acetyldihydrocodeine (9051)................  I
Benzylmorphine (9052)......................  I
Codeine-N-oxide (9053).....................  I
Dihydromorphine (9145).....................  I
Heroin (9200)..............................  I
Morphine-N-oxide (9307)....................  I
Normorphine (9313).........................  I
Pholcodine (9314)..........................  I
Acetylmethadol (9601)......................  I
Allyprodine (9602).........................  I
Alphacetylmethadol except Levo-              I
 Alphacetylmethadol (9603).
Alphameprodine (9604)......................  I
Alphamethadol (9605).......................  I
Betacetylmethadol (9607)...................  I
Betameprodine (9608).......................  I
Betamethadol (9609)........................  I
Betaprodine (9611).........................  I
Hydromorphinol (9627)......................  I
Noracymethadol (9633)......................  I
Norlevorphanol (9634)......................  I
Normethadone (9635)........................  I
Trimeperidine (9646).......................  I
Para-Fluorofentanyl (9812).................  I
3-Methylfentanyl (9813)....................  I
Alpha-methylfentanyl (9814)................  I
Acetyl-alpha-methylfentanyl (9815).........  I
Beta-hydroxyfentanyl (9830)................  I
Beta-hydroxy-3-methylfentanyl (9831).......  I
Alpha-Methylthiofentanyl (9832)............  I
3-Methylthiofentanyl (9833)................  I
Thiofentanyl (9835)........................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Phenmetrazine (1631).......................  II
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Glutethimide (2550)........................  II
Nabilone (7379)............................  II
1-Phenylcyclohexylamine (7460).............  II
Phencyclidine (7471).......................  II
1-Piperidinocyclohexanecarbonitrile (8603).  II
Alphaprodine (9010)........................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Diphenoxylate (9170).......................  II
Benzoylecgonine (9180).....................  II
Ethylmorphine (9190).......................  II
Hydrocodone (9193).........................  II
Levomethorphan (9210)......................  II
Levorphanol (9220).........................  II
Isomethadone (9226)........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Methadone-intermediate (9254)..............  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Levo-alphacetylmethadol (9648).............  II
Oxymorphone (9652).........................  II
Noroxymorphone (9668)......................  II
Alfentanil (9737)..........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to make deuterated and non-deuterated drug 
reference standards which will be distributed to analytical and 
forensic laboratories for drug testing programs.
    No comments or objections have been received.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Cerilliant 
Corporation to manufacture the listed controlled substances is 
consistent with the public interest at this time. DEA has investigated 
Cerilliant Corporation to ensure that the company's registration is 
consistent with the public interest. This investigation included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. Sec. 823 and 28 CFR Secs. 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
above is granted.

    Dated: June 4, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-15835 Filed 6-22-01; 8:45 am]
BILLING CODE 4410-09-M